until they get it.
On prospectively defined secondary endpoints, the bivalent vaccine achieved statistically significant reductions in the rate of genital lesions and viral load from positive swabs, the company said.
Sentiment: Strong Buy
I cannot agree with you more! I think we have some idiot computers trying to suppress relative to 200 day MA. They will lose this battle big time given the contract you discovered.
You are confusing the competitor's drug which I agree if far inferior to PTN's.
may have the signs of HSDD at some point in their life, and as such HSDD represents a major opportunity to address a tremendous medical need with therapies like flibanserin
news in AHs; soaring!
check the news; soaring in AHs
or a bunch of friends. This news is very valuable.
Yahoo removed the topic because of embedded link it seems.